New Haven, CT, United States of America

Michael T Ronan



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 326(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael T Ronan: Innovator in DNA Sequencing

Introduction

Michael T Ronan is a notable inventor based in New Haven, Connecticut. He has made significant contributions to the field of DNA sequencing, particularly through his innovative methods that enhance the efficiency and accuracy of genetic analysis.

Latest Patents

Ronan holds a patent for a groundbreaking invention titled "Double Ended Sequencing." This invention relates to methods of sequencing DNA, specifically focusing on the sequencing of both the sense and antisense strands of DNA. The patented methods involve several key steps, including annealing an unblocked primer to a first strand of nucleic acid, annealing a second blocked primer to a second strand of nucleic acid, elongating the nucleic acid along the first strand with a polymerase, terminating the first sequencing primer, deblocking the second primer, and elongating the nucleic acid along the second strand. This innovative approach has the potential to significantly advance the field of genomics.

Career Highlights

Michael T Ronan is associated with 454 Life Sciences Corporation, a company known for its pioneering work in DNA sequencing technologies. His role at the company has allowed him to contribute to advancements in genetic research and diagnostics.

Collaborations

Ronan has collaborated with esteemed colleagues such as Yi-Ju Chen and John Harris Leamon. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of DNA sequencing.

Conclusion

Michael T Ronan's contributions to DNA sequencing through his patented methods exemplify the importance of innovation in the life sciences. His work continues to influence the way genetic information is analyzed and understood.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…